• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
OncoTree: A Cancer Classification System for Precision Oncology.OncoTree:精准肿瘤学的癌症分类系统。
JCO Clin Cancer Inform. 2021 Feb;5:221-230. doi: 10.1200/CCI.20.00108.
2
Mapping of ICD-O Tuples to OncoTree Codes Using SNOMED CT Post-Coordination.利用 SNOMED CT 后协调将 ICD-O 元组映射到 OncoTree 代码。
Stud Health Technol Inform. 2022 May 25;294:307-311. doi: 10.3233/SHTI220464.
3
Linked Entity Attribute Pair (LEAP): A Harmonization Framework for Data Pooling.关联实体属性对 (LEAP):一种用于数据池化的协调框架。
JCO Clin Cancer Inform. 2020 Aug;4:691-699. doi: 10.1200/CCI.20.00037.
4
Genetic and genomic learning needs of oncologists and oncology nurses in the era of precision medicine: a scoping review.精准医学时代肿瘤学家和肿瘤护士的遗传和基因组学习需求:范围综述。
Per Med. 2022 Mar;19(2):139-153. doi: 10.2217/pme-2021-0096. Epub 2022 Jan 21.
5
[OncoTree-A new classification system for precision oncology].[肿瘤树——一种用于精准肿瘤学的新分类系统]
Chirurgie (Heidelb). 2023 May;94(5):466-467. doi: 10.1007/s00104-023-01865-2. Epub 2023 Apr 15.
6
Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference.精准肿瘤学和基于基因组学的放射治疗:来自美国放射肿瘤学会/美国医学物理学家协会/美国国立癌症研究所精准医学会议的报告。
Int J Radiat Oncol Biol Phys. 2018 Jun 1;101(2):274-284. doi: 10.1016/j.ijrobp.2017.05.044. Epub 2017 Jun 9.
7
Integrating Genomics Into Clinical Pediatric Oncology Using the Molecular Tumor Board at the Memorial Sloan Kettering Cancer Center.通过纪念斯隆凯特琳癌症中心的分子肿瘤委员会将基因组学整合到临床儿科肿瘤学中。
Pediatr Blood Cancer. 2016 Aug;63(8):1368-74. doi: 10.1002/pbc.26002. Epub 2016 Apr 15.
8
Organizing precision medicine: A case study of Memorial Sloan Kettering Cancer Center's engagement in/with genomics.组织精准医学:以纪念斯隆凯特琳癌症中心参与/从事基因组学为例。
Soc Sci Med. 2023 May;324:115789. doi: 10.1016/j.socscimed.2023.115789. Epub 2023 Feb 18.
9
Building a model for disease classification integration in oncology, an approach based on the national cancer institute thesaurus.构建肿瘤学中疾病分类整合模型:一种基于美国国立癌症研究所叙词表的方法。
J Biomed Semantics. 2017 Feb 7;8(1):6. doi: 10.1186/s13326-017-0114-4.
10
Bringing Precision Medicine to Community Oncologists.将精准医学带给社区肿瘤学家。
Cancer Discov. 2017 Jan;7(1):6-7. doi: 10.1158/2159-8290.CD-NB2016-147. Epub 2016 Nov 18.

引用本文的文献

1
Prognostic impact of gene alterations via homologous recombination DNA repair gene alteration status in pancreatic ductal adenocarcinoma.通过同源重组DNA修复基因改变状态的基因改变在胰腺导管腺癌中的预后影响
Front Med (Lausanne). 2025 Aug 25;12:1570731. doi: 10.3389/fmed.2025.1570731. eCollection 2025.
2
Uncovering the Understanding of the Concept of Patient Similarity in Cancer Research and Treatment: Scoping Review.揭示癌症研究与治疗中患者相似性概念的理解:范围综述
J Med Internet Res. 2025 Aug 18;27:e71906. doi: 10.2196/71906.
3
Oncodrive3D: fast and accurate detection of structural clusters of somatic mutations under positive selection.Oncodrive3D:快速准确地检测正选择下体细胞突变的结构簇
Nucleic Acids Res. 2025 Aug 11;53(15). doi: 10.1093/nar/gkaf776.
4
GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling.GPSai:一种在常规肿瘤分析中用于预测组织起源的经过临床验证的人工智能工具。
Cancer Res Commun. 2025 Sep 1;5(9):1477-1489. doi: 10.1158/2767-9764.CRC-25-0171.
5
A highly annotated drug combination resource for catalyzing precision combinatorial therapy.一个用于催化精准联合治疗的高度注释的药物组合资源。
Sci Data. 2025 Jul 23;12(1):1284. doi: 10.1038/s41597-025-05630-4.
6
DNA Damage Repair Pathway Alterations and Immune Landscape Differences in Pediatric/Adolescent, Young Adult (AYA) and Adult Sarcomas.儿童/青少年、青年成人(AYA)及成人肉瘤中的DNA损伤修复途径改变与免疫格局差异
Cancers (Basel). 2025 Jun 12;17(12):1962. doi: 10.3390/cancers17121962.
7
Utilization of a Multi-modal Comprehensive Genomic and Immune Profiling Testing Strategy Results in a High Rate of Test Success and Detection of Clinically Relevant Biomarkers While Optimizing Tissue Usage.采用多模式综合基因组和免疫分析检测策略可实现高检测成功率,检测出临床相关生物标志物,同时优化组织使用。
Mol Diagn Ther. 2025 Jun 7. doi: 10.1007/s40291-025-00793-7.
8
Explainable Machine Learning Identifies Factors for Dosage Compensation in Aneuploid Human Cancer Cells.可解释的机器学习识别非整倍体人类癌细胞中剂量补偿的因素。
bioRxiv. 2025 May 13:2025.05.12.653427. doi: 10.1101/2025.05.12.653427.
9
Retrospective database study of druggable mutation detection among patients with non-small cell lung cancer in Japan.日本非小细胞肺癌患者中可靶向治疗突变检测的回顾性数据库研究。
Sci Rep. 2025 May 21;15(1):17692. doi: 10.1038/s41598-025-02216-3.
10
Whole genome sequencing improves tissue-of-origin diagnosis and treatment options for cancer of unknown primary.全基因组测序可改善原发灶不明癌症的组织来源诊断及治疗方案。
Nat Commun. 2025 May 20;16(1):4422. doi: 10.1038/s41467-025-59661-x.

本文引用的文献

1
Linked Entity Attribute Pair (LEAP): A Harmonization Framework for Data Pooling.关联实体属性对 (LEAP):一种用于数据池化的协调框架。
JCO Clin Cancer Inform. 2020 Aug;4:691-699. doi: 10.1200/CCI.20.00037.
2
Commentary: Cancer research quality and tumour classification.评论:癌症研究质量与肿瘤分类
Tumour Biol. 2020 Feb;42(2):1010428320907544. doi: 10.1177/1010428320907544.
3
Cancer taxonomy: pathology beyond pathology.癌症分类学:超越病理学的病理。
Eur J Cancer. 2019 Jul;115:57-60. doi: 10.1016/j.ejca.2019.03.026. Epub 2019 May 17.
4
HER kinase inhibition in patients with HER2- and HER3-mutant cancers.曲妥珠单抗治疗 HER2 和 HER3 突变型癌症患者的 HER 激酶抑制作用。
Nature. 2018 Feb 8;554(7691):189-194. doi: 10.1038/nature25475. Epub 2018 Jan 31.
5
OncoKB: A Precision Oncology Knowledge Base.OncoKB:一个精准肿瘤知识库。
JCO Precis Oncol. 2017 Jul;2017. doi: 10.1200/PO.17.00011. Epub 2017 May 16.
6
AACR Project GENIE: Powering Precision Medicine through an International Consortium.美国癌症研究协会(AACR)项目GENIE:通过国际联盟推动精准医学发展。
Cancer Discov. 2017 Aug;7(8):818-831. doi: 10.1158/2159-8290.CD-17-0151. Epub 2017 Jun 1.
7
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.从10000例患者的前瞻性临床测序中揭示的转移性癌症的突变图谱。
Nat Med. 2017 Jun;23(6):703-713. doi: 10.1038/nm.4333. Epub 2017 May 8.
8
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.2016 年版世界卫生组织髓系肿瘤和急性白血病分类。
Blood. 2016 May 19;127(20):2391-405. doi: 10.1182/blood-2016-03-643544. Epub 2016 Apr 11.
9
The 2016 revision of the World Health Organization classification of lymphoid neoplasms.《世界卫生组织淋巴组织肿瘤分类(2016年修订版)》
Blood. 2016 May 19;127(20):2375-90. doi: 10.1182/blood-2016-01-643569. Epub 2016 Mar 15.
10
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.错配修复缺陷肿瘤中的程序性死亡受体-1阻断
N Engl J Med. 2015 Jun 25;372(26):2509-20. doi: 10.1056/NEJMoa1500596. Epub 2015 May 30.

OncoTree:精准肿瘤学的癌症分类系统。

OncoTree: A Cancer Classification System for Precision Oncology.

机构信息

Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY.

出版信息

JCO Clin Cancer Inform. 2021 Feb;5:221-230. doi: 10.1200/CCI.20.00108.

DOI:10.1200/CCI.20.00108
PMID:33625877
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8240791/
Abstract

PURPOSE

Cancer classification is foundational for patient care and oncology research. Systems such as International Classification of Diseases for Oncology (ICD-O), Systematized Nomenclature of Medicine Clinical Terms (SNOMED-CT), and National Cancer Institute Thesaurus (NCIt) provide large sets of cancer classification terminologies but they lack a dynamic modernized cancer classification platform that addresses the fast-evolving needs in clinical reporting of genomic sequencing results and associated oncology research.

METHODS

To meet these needs, we have developed OncoTree, an open-source cancer classification system. It is maintained by a cross-institutional committee of oncologists, pathologists, scientists, and engineers, accessible via an open-source Web user interface and an application programming interface.

RESULTS

OncoTree currently includes 868 tumor types across 32 organ sites. OncoTree has been adopted as the tumor classification system for American Association for Cancer Research (AACR) Project Genomics Evidence Neoplasia Information Exchange (GENIE), a large genomic and clinical data-sharing consortium, and for clinical molecular testing efforts at Memorial Sloan Kettering Cancer Center and Dana-Farber Cancer Institute. It is also used by precision oncology tools such as OncoKB and cBioPortal for Cancer Genomics.

CONCLUSION

OncoTree is a dynamic and flexible community-driven cancer classification platform encompassing rare and common cancers that provides clinically relevant and appropriately granular cancer classification for clinical decision support systems and oncology research.

摘要

目的

癌症分类是患者护理和肿瘤学研究的基础。国际肿瘤疾病分类(ICD-O)、医学系统命名法临床术语(SNOMED-CT)和国家癌症研究所术语(NCIt)等系统提供了大量的癌症分类术语,但它们缺乏一个动态的现代化癌症分类平台,无法满足临床报告基因组测序结果和相关肿瘤学研究中快速发展的需求。

方法

为了满足这些需求,我们开发了 OncoTree,这是一个开源的癌症分类系统。它由一个跨机构的肿瘤学家、病理学家、科学家和工程师委员会维护,可通过开源 Web 用户界面和应用程序编程接口访问。

结果

OncoTree 目前包括 32 个器官部位的 868 种肿瘤类型。OncoTree 已被美国癌症研究协会(AACR)项目基因组学证据肿瘤信息交换(GENIE)采用为肿瘤分类系统,该项目是一个大型基因组和临床数据共享联盟,并且在纪念斯隆凯特琳癌症中心和丹娜-法伯癌症研究所进行临床分子检测工作时也采用了该系统。它还被 OncoKB 和 cBioPortal for Cancer Genomics 等精准肿瘤学工具用于癌症分类。

结论

OncoTree 是一个动态灵活的社区驱动的癌症分类平台,涵盖了罕见和常见的癌症,为临床决策支持系统和肿瘤学研究提供了临床相关和适当细化的癌症分类。